Issuer (NYSE: BR) insider files Form 144 to sell 10,214 shares
Rhea-AI Filing Summary
An affiliate of the issuer filed a Form 144 notice to sell 10,214 shares of common stock through Morgan Stanley Smith Barney LLC on or about 12/03/2025 on the NYSE. The filing lists an aggregate market value of $2,341,617.72 for the planned sale and notes that 116,727,559 shares of this class were outstanding.
The securities to be sold were acquired through restricted stock vesting and stock option exercises under registered plans. These include 1,150 shares from restricted stock vesting on 11/11/2024 and option exercises for 3,516 and 5,548 shares on 12/03/2025, with the option exercises paid in cash. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
Positive
- None.
Negative
- None.
FAQ
How many shares are covered by this Form 144 filing for BR?
The Form 144 notice covers the proposed sale of 10,214 shares of the issuer’s common stock, to be sold through Morgan Stanley Smith Barney LLC on the NYSE.
What is the aggregate market value of the shares in this BR Form 144?
The filing reports an aggregate market value of $2,341,617.72 for the 10,214 common shares covered by the notice.
How and when were the BR shares in this Form 144 acquired?
The securities were acquired under registered plans: 1,150 shares from restricted stock vesting on 11/11/2024, and option exercises for 3,516 and 5,548 shares on 12/03/2025, with the option exercises paid in cash.
What is the total number of BR shares outstanding referenced in this Form 144?
The notice states that there were 116,727,559 shares of the class of common stock outstanding at the time referenced in the form.
Which broker is handling the sale in this BR Form 144 filing?
The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
What representation does the seller make in this BR Form 144 notice?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.